BNC Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.8M Buy
9,352
+3,413
+57% +$4.03M 2.48% 9
2026
Q2
$7.12M Buy
+5,939
New +$6.07M 1.72% 20
2026
Q1
– Sell
-227
Closed -$244K – 115
2025
Q4
$244K Buy
+227
New +$217K 0.06% 95
2024
Q3
– Sell
-225
Closed -$204K – 103
2024
Q2
$204K Buy
+225
New +$180K 0.08% 96
2023
Q1
– Sell
-7,190
Closed -$2.63M – 117
2022
Q4
$2.63M Buy
+7,190
New +$2.55M 1.55% 17
2020
Q4
– Sell
-122
Closed -$18K – 309
2020
Q3
$18K Buy
+122
New +$18.9K 0.01% 239

Other funds holding LLY

BNC Wealth Management's LLY Position: Q3 2026 in Review

BNC Wealth Management increased its Eli Lilly (LLY) stake by 57% in Q3 2026, buying an estimated $4.03M and bringing the position to 9,352 shares worth $10.8M. The position accounts for 2.48% of the portfolio, ranked #9.

BNC Wealth Management first reported a position in LLY in Q3 2020 and has held it in 6 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • BNC Wealth Management held 9,352 shares of Eli Lilly worth $10.8M as of Q3 2026.
  • BNC Wealth Management bought 3,413 Eli Lilly shares in Q3 2026, an estimated $4.03M.
  • Eli Lilly made up 2.48% of BNC Wealth Management's portfolio in Q3 2026, its #9 holding.
  • BNC Wealth Management first reported a position in Eli Lilly in Q3 2020 and has held it in 6 quarters since.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on BNC Wealth Management's 13F filing for Q3 2026, filed 19 Oct 2026.